Cyclophosphamide Injection 1 g.
Sponsors
Ospedale Pediatrico Bambino Gesu', Iovance Biotherapeutics Inc., Medical University Of Vienna
Conditions
Metastatic Non-Small-Cell Lung CancerNeoplasmRelapsed/refractory B-cell Acute Lymphoblastic LeukemiaRelapsed/refractory CD7+ T-cell Acute Lymphoblastic Leukemia/Lymphomaependymoma and atypical teratoid rhabdoid tumor (ATRT)rare CNS tumorsrecurrent/progressive medulloblastoma
Phase 1
Phase I clinical trial on the use of fresh, allogeneic, second-generation CD19-CAR T cells for treatment of children and young adult with relapsed/refractory B-cell Acute Lymphoblastic Leukemia
RecruitingCTIS2023-508420-36-00
Start: 2024-04-23Target: 24Updated: 2024-04-23
Phase I/II study of anti-CD7 Chimeric Antigen Receptor-Expressing T cells in pediatric patients/young adult affected by relapsed/refractory CD7+ T-cell Acute Lymphoblastic Leukemia/Lymphoma
RecruitingCTIS2023-508355-39-00
Start: 2024-04-20Target: 26Updated: 2024-10-16
Phase 2
A Phase 2 Multicenter Study of Autologous Tumor Infiltrating Lymphocytes (LN-145) in Patients with Metastatic Non-Small-Cell Lung Cancer
RecruitingCTIS2024-510778-26-00
Start: 2025-12-19Target: 115Updated: 2025-11-26
A Phase 2, Multicenter Study of Autologous Tumor Infiltrating Lymphocytes (LN-144/LN-145/LN-145-S1) in Patients with Solid Tumors
Active, not recruitingCTIS2024-510779-39-00
Start: 2018-12-19Target: 95Updated: 2026-01-21
MEMMAT - Medulloblastoma European Multitarget Metronomic Anti-Angiogenic Trial - A Phase II study of metronomic and targeted anti-angiogenesis therapy for children with recurrent/progressive medulloblastoma, ependymoma, ATRT and rare CNS tumors
RecruitingCTIS2024-515626-92-00
Start: 2013-10-18Target: 100Updated: 2025-11-28